Literature DB >> 1071379

Behavioral and biologic aspects of marijuana use.

J H Mendelson, T F Babor, J C Kuehnle, A M Rossi, J G Bernstein, N K Mello, I Greenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1071379     DOI： 10.1111/j.1749-6632.1976.tb49899.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

2.  Effects of acute marijuana smoking in post-menopausal women.

Authors:  R A Benedikt; P Cristofaro; J H Mendelson; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Effects of acute marijuana smoking on pulse rate and mood states in women.

Authors:  B W Lex; J H Mendelson; S Bavli; K Harvey; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.

Authors:  Elisa Pabon; Frederica Rockwood; Greg J Norman; Harriet de Wit
Journal:  Psychophysiology       Date:  2021-10-19       Impact factor: 4.348

5.  The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.

Authors:  Marco Bortolato; Gian Nicola Aru; Roberto Frau; Marco Orrù; Grant Christopher Luckey; Gianluca Boi; Gian Luigi Gessa
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

6.  Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers.

Authors:  David A Gorelick; Robert S Goodwin; Eugene Schwilke; David M Schwope; William D Darwin; Deanna L Kelly; Robert P McMahon; Fang Liu; Catherine Ortemann-Renon; Denis Bonnet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2012-10-16       Impact factor: 3.367

7.  Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use.

Authors:  J H Mendelson; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.

Authors:  Michael A P Bloomfield; Celia J A Morgan; Shitij Kapur; H Valerie Curran; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

9.  Cannabis and tolerance: acute drug impairment as a function of cannabis use history.

Authors:  J G Ramaekers; J H van Wel; D B Spronk; S W Toennes; K P C Kuypers; E L Theunissen; R J Verkes
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

10.  Salience attribution and its relationship to cannabis-induced psychotic symptoms.

Authors:  M A P Bloomfield; E Mouchlianitis; C J A Morgan; T P Freeman; H V Curran; J P Roiser; O D Howes
Journal:  Psychol Med       Date:  2016-09-15       Impact factor: 7.723
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.